Interventions for chronic palmoplantar pustulosis

Review (37 RCTs, n=1,663) found maxacalcitol may be more effective than placebo in achieving clearance in the short term; and secukinumab and guselkumab are probably superior to placebo in reducing severity.

Source:

Cochrane Database of Systematic Reviews